Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Healius Ltd

HLS.AX ✗ NOT COMPLIANT ☆ Track — members

ASX · Healthcare · Healthcare Facilities & Services ·

Australia Micro Cap Analyst: SELL

Last Close

$0.28

▼ -4.76%

Market Cap $204.89M · Vol 2.92M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$204.89M

Micro Cap

Div Yield

0.00%

Annual dividend

EPS Growth

+58.65%

YoY

RSI (14)

67.74

Momentum

Beta

0.69

vs Market

52W High

$0.76

59.66% below

52W Low

$0.21

34.34% above

Volume

2.92M

Avg 2.32M

P/B

0.97

Price-to-book

ROE

-3.05%

Return on equity

Free Float

77.50%

Public shares

Shariah Compliance8 STANDARDS

✗ Healius Ltd (HLS.AX) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does HLS.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-4.76%

+0.00%

+8.11%

-48.39%

YTD

-55.80%

-50.00%

-78.62%

-88.38%

Financials & Valuation

TTM · Annual

Total Revenue	$884.48M
Net Income	$-370,453,229.00
Revenue Growth (YoY)	+3.90%
Gross Margin	67.39%
Operating Margin	0.01%
Net Profit Margin	-41.88%
ROE	-3.05%
ROA · ROIC	-24.88% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.42
P/B	0.97
P/FCF	3.89
EPS Growth	+58.65%
Outstanding Shares	726.16M

Technical Indicators

50-Day SMA	$0.27
200-Day SMA	$0.45
RSI (14)	67.74
Beta	0.69
52-Week High	$0.76
52-Week Low	$0.21

Volume Today	2.92M
Avg Daily Volume (30D)	2.32M
Relative Volume	1.26x
Volatility (10D)	53.87
Volatility (30D)	49.88
Free Float	77.50%

Analyst Consensus

SELL

Current Price $0.28

Mean Target $0.29

52W Low$0.21 52W High$0.76

Current

Target

$0.21 $0.76

Current Analyst target

+3.41% upside potential · 10 analysts

Identifiers

ExchangeASX

FIGIBBG001S5SNJ4

ISINAU0000033359

CountryAustralia

Sub-IndustryMedical & Diagnostic Laboratories

Earnings DateAug 18, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

NTRA Natera Inc -0.27% LH Labcorp Holdings Inc -1.38% RDNT RadNet Inc -1.24% LALPATHLAB.NS Dr. Lal PathLabs Ltd -2.65% WGS GeneDx Holdings Corp -1.35%

Company Profile

Healius Limited is a healthcare company. The Company's specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include Abbot, Agilex Biolabs, Dorevitch, Gastrolab, Genomic Diagnostics, IQ Pathology, Kossard Dermatopathology, Laverty Pathology, QML Pathology, TML Pathology, Vetnostics Pathology and Western Diagnostic Pathology (WDP). These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia.